Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Less cholesterol means better tumor killing for cytotoxic T9 cells.

Griesenauer B, Paczesny S.

J Exp Med. 2018 May 15. pii: jem.20180852. doi: 10.1084/jem.20180852. [Epub ahead of print]

PMID:
29764914
2.

Specifically differentiated T cell subset promotes tumor immunity over fatal immunity.

Ramadan A, Griesenauer B, Adom D, Kapur R, Hanenberg H, Liu C, Kaplan MH, Paczesny S.

J Exp Med. 2017 Dec 4;214(12):3577-3596. doi: 10.1084/jem.20170041. Epub 2017 Oct 16.

PMID:
29038366
3.

An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition.

Forcade E, Paz K, Flynn R, Griesenauer B, Amet T, Li W, Liu L, Bakoyannis G, Jiang D, Chu HW, Lobera M, Yang J, Wilkes DS, Du J, Gartlan K, Hill GR, MacDonald KP, Espada EL, Blanco P, Serody JS, Koreth J, Cutler CS, Antin JH, Soiffer RJ, Ritz J, Paczesny S, Blazar BR.

JCI Insight. 2017 Jun 15;2(12). pii: 92111. doi: 10.1172/jci.insight.92111. [Epub ahead of print]

4.

The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases.

Griesenauer B, Paczesny S.

Front Immunol. 2017 Apr 24;8:475. doi: 10.3389/fimmu.2017.00475. eCollection 2017. Review.

5.

ST2 blockade reduces sST2-producing T cells while maintaining protective mST2-expressing T cells during graft-versus-host disease.

Zhang J, Ramadan AM, Griesenauer B, Li W, Turner MJ, Liu C, Kapur R, Hanenberg H, Blazar BR, Tawara I, Paczesny S.

Sci Transl Med. 2015 Oct 7;7(308):308ra160. doi: 10.1126/scitranslmed.aab0166.

6.

A recent evolutionary origin of a bacterial small RNA that controls multicellular fruiting body development.

Chen IC, Griesenauer B, Yu YT, Velicer GJ.

Mol Phylogenet Evol. 2014 Apr;73:1-9. doi: 10.1016/j.ympev.2014.01.001. Epub 2014 Jan 10.

Supplemental Content

Loading ...
Support Center